Evaluating Colonoscopy Quality by Performing Provider Type

Emily Berry, Jeff Hostetter, Joseph Bachtold, Sarah Zamarripa, Keith E Argenbright
{"title":"Evaluating Colonoscopy Quality by Performing Provider Type","authors":"Emily Berry, Jeff Hostetter, Joseph Bachtold, Sarah Zamarripa, Keith E Argenbright","doi":"10.1093/jnci/djae080","DOIUrl":null,"url":null,"abstract":"Background Colorectal Cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer death in the United States. Colonoscopy is an essential tool for screening, used both as a primary approach and follow-up to an abnormal stool-based CRC screening result. Colonoscopy quality is often measured with four key indicators: bowel preparation, cecal intubation, mean withdrawal time, and adenoma detection. Colonoscopies are most often performed by gastroenterologists (GI), however, in rural and medically underserved areas non-GI providers often perform colonoscopies. This study aims to evaluate the quality and safety of screening colonoscopies performed by non-GI providers, comparing their outcomes to those of GI providers. Methods Descriptive statistics were used to characterize the study population. Results for quality indicators were stratified by provider type and compared. Statistical significance was determined using p < 0.05 as the threshold for all comparisons; all p-values were two-sided. Results No statistical difference was found when comparing performance by provider type. Median performance for gastroenterologists, general surgeons, and family medicine providers ranged form 98—100% for cecal intubation; 97.4—100% for bowel preparation; 57.4—88.9% for male adenoma detection rate; 47.7—62.13% for female adenoma detection rate; and 0:12:10—0:20:16 for mean withdrawal time. All provider types met and exceeded the goal metric for each of the quality indicators (p < 0.001). In this analysis, non-GI providers can be expected to perform colonoscopies with similar quality to GI providers based on performance outcomes for the key quality metrics.","PeriodicalId":501635,"journal":{"name":"Journal of the National Cancer Institute","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jnci/djae080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Colorectal Cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer death in the United States. Colonoscopy is an essential tool for screening, used both as a primary approach and follow-up to an abnormal stool-based CRC screening result. Colonoscopy quality is often measured with four key indicators: bowel preparation, cecal intubation, mean withdrawal time, and adenoma detection. Colonoscopies are most often performed by gastroenterologists (GI), however, in rural and medically underserved areas non-GI providers often perform colonoscopies. This study aims to evaluate the quality and safety of screening colonoscopies performed by non-GI providers, comparing their outcomes to those of GI providers. Methods Descriptive statistics were used to characterize the study population. Results for quality indicators were stratified by provider type and compared. Statistical significance was determined using p < 0.05 as the threshold for all comparisons; all p-values were two-sided. Results No statistical difference was found when comparing performance by provider type. Median performance for gastroenterologists, general surgeons, and family medicine providers ranged form 98—100% for cecal intubation; 97.4—100% for bowel preparation; 57.4—88.9% for male adenoma detection rate; 47.7—62.13% for female adenoma detection rate; and 0:12:10—0:20:16 for mean withdrawal time. All provider types met and exceeded the goal metric for each of the quality indicators (p < 0.001). In this analysis, non-GI providers can be expected to perform colonoscopies with similar quality to GI providers based on performance outcomes for the key quality metrics.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
按医疗机构类型评估结肠镜检查质量
背景 大肠癌(CRC)是美国第三大确诊癌症和第二大癌症死因。结肠镜检查是筛查的重要工具,既可作为初筛方法,也可作为粪便异常 CRC 筛查结果的后续检查。结肠镜检查的质量通常用四个关键指标来衡量:肠道准备、盲肠插管、平均退出时间和腺瘤检测。结肠镜检查通常由消化内科医生(GI)进行,但在农村和医疗服务不足的地区,非 GI 医疗服务提供者通常也会进行结肠镜检查。本研究旨在评估非 GI 医疗机构进行结肠镜筛查的质量和安全性,并将其结果与 GI 医疗机构的结果进行比较。方法 使用描述性统计来描述研究人群的特征。根据医疗机构类型对质量指标的结果进行分层并进行比较。所有比较均以 p < 0.05 为临界值,所有 p 值均为双侧。结果 在按医疗机构类型比较绩效时,未发现统计差异。消化内科医生、普外科医生和全科医生在盲肠插管方面的绩效中位数为 98%-100%;肠道准备方面为 97.4%-100%;男性腺瘤检出率为 57.4%-88.9%;女性腺瘤检出率为 47.7%-62.13%;平均退出时间为 0:12:10-0:20:16。所有类型的医疗服务提供者都达到或超过了每项质量指标的目标指标(p < 0.001)。在这项分析中,根据关键质量指标的绩效结果,非消化道医疗服务提供者的结肠镜检查质量与消化道医疗服务提供者类似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Elevated risk of lung cancer among asian American females who have never smoked: an emerging cancer disparity First Cycle Toxicity and Survival in Patients with Rare Cancers Treated with Checkpoint Inhibitors The Association of Where Patients with Prostate Cancer Live and Receive Care on Racial Treatment Inequities Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling Proinflammatory Dietary Pattern and Risk of Total and Subtypes of Breast Cancer Among U.S. Women
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1